logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
R

Riitta Lassila

university of helsinki

43H指数
332论文数
6.6K被引数
收录论文 137
发表时间
logo
Personalized Treatment of Hemophilia: Matching Therapies to Patient Needs in a Rapidly Evolving Landscape血友病的个性化治疗：在快速发展的领域中匹配疗法以满足患者需求
errDrugs
IF14.4
err2026-09-25
err0
errOAAI
errTimea Szanto; Riitta Lassila
err分享
err收藏
A novel p.C1130S mutation in a Finnish family with a complex phenotype of von Willebrand disease一个芬兰家庭中von Willebrand疾病复杂表型的一种新型p.C1130S突变
errHaematologica
IF7.9
err2026-02-01
err0
errOAAI
errCalcoen, Bas; Portier, Irina; Pareyn, Inge; Vandenbulcke, Aline; Lehtinen, Anna-Elina; Lassila, Riitta; Tersteeg, Claudia; Vanhoorelbeke, Karen; De Meyer, Simon F.; Szanto, Timea
err分享
err收藏
Advances in Von Willebrand Disease血管性血友病的研究进展
errHAEMOPHILIA
IF3
err2025-12-01
err0
PREAI
errLassila, Riitta; Atiq, Ferdows; Casari, Caterina; Lavin, Michelle
err分享
err收藏
Early outpatient use of low-molecular-weight heparin benefits COVID-19 outcome in association with hospitalization - Lessons learned早期低分子量肝素门诊使用可改善与住院相关的COVID-19结局——经验教训
errThrombosis Research
IF3.4
err2025-11-26
err0
PREAI
errMiika Koskinen; Eeva Ruotsalainen; Mia Wallin; Hilkka Kivelä; Kerstin Carlsson; Jari Petäjä; Eero Hirvensalo; Markku Mäkijärvi; Riitta Lassila
err分享
err收藏
Health-Related Quality of Life, Physical Activity and Joint Health in People With Severe Haemophilia A Receiving Emicizumab: Results From the Phase IV HemiNorth 2 Study与健康相关的生活质量、身体活动及关节健康在重度A型血友病患者接受依库珠单抗治疗中的情况：HemiNorth 2 IV期研究结果
errHAEMOPHILIA
IF3
err2025-09-01
err0
errOAAI
errAstermark, Jan; Ranta, Susanna; Myrin-Westesson, Linda; Hoffmann, Marianne; Quere, Sandrine; Sanchez, Amparo Yovanna Castro; Robson, Susan; Czirok, Tunde; Lassila, Riitta; Holme, Pal Andre
err分享
err收藏
Switching From Standard to Extended Half-Life Coagulation Factor Replacement in Haemophilia: Clinical Outcomes and Costs of Care in Finland从标准半衰期凝血因子替代疗法转换为延长半衰期凝血因子替代疗法在血友病中的应用：芬兰的临床结局与治疗费用
errHaemophilia
IF3
err2025-06-21
err0
errOAAI
errMirkka Koivusalo; Timea Szanto; Tuomas Kovalainen; Aino Vesikansa; Outi Laine; Anu Partanen; Timo Siitonen; Marko Vesanen; Juha Mehtälä; Nina Sarnesto; Johanna Haapkylä; Anna-Elina Lehtinen; Riitta Lassila
err分享
err收藏
Assessing the diagnostic value of oncological biomarkers for identifying primary malignancies in skeletal metastatic disease
errEJSO
IF2.9
err2025-06-01
err0
PREAI
errMatilainen, Sanna; Liikanen, Hanna; Lassila, Riitta; Laitinen, Minna K.
err分享
err收藏
Antiplatelet-anticoagulant, APAC, a mimic of endogenous heparin, is an antithrombotic with von Willebrand factor-mediated characteristics抗血小板-抗凝血剂，APAC，一种内源性肝素的模拟物，是一种具有冯·维勒布兰德因子介导特性的抗血栓药物。
errTHROMBOSIS RESEARCH
IF3.4
err2025-06-01
err0
PREAI
errJouppila, Annukka; Nevola, Ilja; Lemponen, Marja; Mattila, Tomi; Lassila, Riitta
err分享
err收藏
Inhibitor development in nonsevere hemophilia: data from the European Haemophilia Safety Surveillance (EUHASS) registry非重度血友病患者中的抑制剂发展：欧洲血友病安全监测（EUHASS）登记研究的数据
errResearch and Practice in Thrombosis and Haemostasis
IF3.4
err2025-05-01
err0
errOAAI
errKathelijn Fischer; Riitta Lassila; Flora Peyvandi; Alexander Gatt; Samantha C. Gouw; Robert Hollingsworth; Thierry Lambert; Radek Kaczmarek; Diana Carbonero Alvarez; Michael Makris
err分享
err收藏
Antithrombotic therapy in patients with inherited bleeding disorders: practical considerations
errPOLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ
IF4.7
err2025-04-01
err0
errOAAI
errWindyga, Jerzy; Lassila, Riitta
err分享
err收藏
Trends in Treatment of Severe Haemophilia and Impact on Inhibitor Assessment by the EUHASS Registry
errHAEMOPHILIA
IF3
err2025-04-01
err0
errOAAI
errFischer, Kathelijn; Lassila, Riitta; Peyvandi, Flora; Gatt, Alex; Gouw, Samantha C.; Hollingsworth, Rob; Lambert, Thierry; Kaczmarek, Radoslaw; Carbonero, Diana; Makris, Michael
err分享
err收藏
Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Haemate P) in von Willebrand Disease: A Systematic Review and Pharmacovigilance Update血管性血友病的血浆源性血管性血友病因子/因子VIII浓缩物 (血红素P): 系统评价和药物警戒更新
errHAEMOPHILIA
IF3
err2025-02-09
err0
errOAAI
errEttingshausen, Carmen Escuriola; Lassila, Riitta; Escolar, Gines; Male, Christoph; Schirner, Kathrin; Heyder, Lisa; Berntorp, Erik
err分享
err收藏
Use of antithrombotic therapy in patients with hemophilia: a selected synopsis of the European Hematology Association- International Society on Thrombosis and Haemostasis- European Association for Hemophilia and Allied Disorders- European Stroke Organization Clinical Practice Guidance document
errJOURNAL OF THROMBOSIS AND HAEMOSTASIS
IF5
err2025-02-01
err0
errOAAI
errEscobar, Miguel; Lassila, Riitta; Bekdache, Carine; Owaidah, Tarek; Sholzberg, Michelle
err分享
err收藏
Venous thromboembolism treatment failure during use of factor Xa inhibitors-association with thoracic outlet syndrome and development of chronic thromboembolic pulmonary hypertension
errANNALS OF MEDICINE
IF4.3
err2024-12-03
err0
errOAAI
errKaksonen, Matti; Simonen, Piia; Lassila, Riitta; Pentikainen, Markku
err分享
err收藏
Nonneutralizing antibodies in Nordic persons with moderate hemophilia A and B (the MoHem study)患有中度血友病A和B的北欧人的非中和抗体 (MoHem研究)
errRESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS
IF3.4
err2024-11-01
err0
errOAAI
errMaseide, Ragnhild J.; Berntorp, Erik; Astermark, Jan; Olsson, Anna; Bruzelius, Maria; Frisk, Tony; Nummi, Vuokko; Lassila, Riitta; Strandberg, Karin; Tjonnfjord, Geir E.; Holme, Pal A.
err分享
err收藏
Prognostic role of the neutrophil/lymphocyte ratio in high-risk BCG-naïve non-muscle-invasive bladder cancer treated with intravesical gemcitabine/docetaxel中性粒细胞/淋巴细胞比值在吉西他滨/多西他赛膀胱灌注治疗高危BCG初治非肌层浸润性膀胱癌中的预后作用
errBJU INTERNATIONAL
IF4.4
err2024-07-31
err3
PREAI
errChakra, Mohamad Abou; Lassila, Riitta; El Beayni, Nancy; Mott, Sarah L.; O'Donnell, Michael A.
err分享
err收藏
Moving towards Normalization of haemostasis and health equity: Evolving treatment goals for haemophilia A
errHAEMOPHILIA
IF3
err2024-07-10
err3
PREAI
errHolme, Pal Andre; Blatny, Jan; Chowdary, Pratima; Lassila, Riitta; O'Connell, Niamh; Hermans, Cedric; Roman, Maria Teresa Alvarez; Negrier, Claude; Coppola, Antonio; Oldenburg, Johannes
err分享
err收藏
Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS)严重血友病暴露50天后根据浓缩物进行抑制剂开发: 来自欧洲血友病安全监测 (EUHASS) 的数据
errRESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS
IF3.4
err2024-05-01
err3
errOAAI
errFischer, Kathelijn; Lassila, Riitta; Peyvandi, Flora; Gatt, Alexander; Gouw, Samantha C.; Hollingsworth, Rob; Lambert, Thierry; Kaczmarek, Radek; Carbonero, Diana; Makris, Mike
err分享
err收藏
Highly thrombogenic phenotype and impaired wound healing in a patient with congenital dysfibrinogenemia: case report
errRESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS
IF3.4
err2024-05-01
err0
errOAAI
errEl Beayni, Nancy; Szanto, Timea; Neerman-Arbez, Marguerite; Casini, Alessandro; Lassila, Riitta
err分享
err收藏
Challenges in ageing persons with haemophilia老年血友病患者面临的挑战
errHAEMOPHILIA
IF3
err2024-03-27
err0
PREAI
errMakris, Michael; Lassila, Riitta; Kennedy, Megan
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
J
Jaakko Kaprio
H 指数: 187 · 论文数: 2.4K
P
Philippe Gabríel Steg
H 指数: 180 · 论文数: 2.1K
T
Thomas F. Lüscher
H 指数: 159 · 论文数: 2.6K
L
Lars Wallentin
H 指数: 148 · 论文数: 1.2K
O
Olli T. Raitakari
H 指数: 143 · 论文数: 1.4K
查看更多